For the pharmaceutical industry the drive to achieve greater sustainability goes hand-in-hand with a commitment to maintain and improve patient outcomes. Collaboration with aligned partners is critical to the attainment of this goal with regulation complicating progress.
In this article, experts from Aptar Pharma discuss the commitments and progress that the company has made towards greater sustainability focusing on the concept and delivery of a circular economy.
The importance of collaboration with organizations such as the Ellen MacArthur Foundation (Cowes, UK) and the World Business Council for Sustainable Development is highlighted. Case studies provide practical examples of what has been achieved to date and plans for the future are outlined.